Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients - Institut Pierre Louis d'Epidémiologie et de Santé Publique Accéder directement au contenu
Article Dans Une Revue Clinical Infectious Diseases Année : 2021

Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients

Résumé

A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.
Fichier principal
Vignette du fichier
Mazzola et al. - 2021 - Poor Antibody Response after Two Doses of SARS-CoV.pdf (217.28 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03286710 , version 1 (15-07-2021)

Identifiants

Citer

Alessandra Mazzola, Eve Todesco, Sarah Drouin, Fanny Hazan, Stéphane Marot, et al.. Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients. Clinical Infectious Diseases, 2021, ⟨10.1093/cid/ciab580⟩. ⟨hal-03286710⟩
52 Consultations
45 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More